BACKGROUND: Left ventricular hypertrophy (LVH) and prolonged QT interval at ECG (QTc) are common in both obesity and arterial hypertension (AH), and are risk factors for cardiovascular disease and sudden death. METHODS: We compared the frequencies of LVH (ECG criteria) and QTc in obese-AH (n ¼ 41), in normotensive obese (n ¼ 75), in lean-AH (n ¼ 30), and in lean controls (n ¼ 68) comparable for age and sex; in obese patients, LVH and QTc were evaluated under basal conditions and 1 y later, that is, after a significant weight loss induced by bariatric surgery. RESULTS: LVH was more frequent, and QTc was longer, in obese-AH, in normotensive obese, and in lean-AH than in lean controls; after weight loss, frequency of LVH decreased in obese subjects becoming normotensive (n ¼ 87), not in obese subjects remaining hypertensive (n ¼ 29), while QTc decreased in all obese subjects. CONCLUSION: Weight loss can effectively reduce QTc; when concomitant AH disappears, weight loss can also reduce the prevalence of LVH. In obese patients remaining hypertensive, aggressive pharmacological treatment is therefore indicated to correct LVH.
Introduction
Obesity is an independent risk factor for cardiovascular diseases such as arterial hypertension, congestive heart failure, and ischaemic heart disease, [1] [2] [3] and has been proposed as a risk factor for ventricular arrhythmias and sudden death. 3, 4 Left ventricular hypertrophy (LVH), as assessed through ECG criteria (Cornell voltage-duration product) or through echocardiography, is frequent in both obesity and arterial hypertension, especially when obesity and hypertension coexist. 5, 6 Prolonged corrected QT interval (QTc) has been reported in cardiac failure, 7 in arterial hypertension, particularly in the presence of LVH, 8, 9 in ischaemic heart disease, 10, 11 and in obesity. 12 QTc is an index of physiological variability of ventricular repolarisation, and an increase of QTc is a possible risk factor for ventricular arrhythmias and sudden death; 7 in addition, prolonged QTc is an index of sympathetic overactivity under several cardiac conditions, [13] [14] [15] and previous studies have shown that increased sympathetic activation is present in both obesity and hypertension, particularly when the two conditions co-exist. 16 Conflicting evidence suggests that weight loss can decrease LVH; the oldest papers indicated that weight loss, even when substantial, does not reduce LVH, 17, 18 but afterwards it was reported that even an 8 kg loss could decrease LVH; 19, 20 however, the number of patients enrolled in these studies was quite small, [17] [18] [19] [20] [21] and control subjects were not included. In the largest study published so far, 41 surgery operated patients had weight loss, reduced systolic and diastolic blood pressure, and reduced LVH; 31 diet-treated patients had no reduction in either body weight, blood pressure, or LVH. 22 Therefore, it is not possible to conclude that weight loss per se or decrease in arterial blood pressure per se was the key factor in decreasing LVH.
Only a few studies analysed the effects of weight loss on QTc, yielding conflicting results: [23] [24] [25] [26] [27] [28] [29] [30] prolongation of QTc or sudden death has been reported with very low calorie diets (VLCD), [24] [25] [26] [27] while shortening of QTc has been reported with low calorie diet (LCD). 23, 28, 30 Bariatric surgery appears the treatment of choice for subjects with morbid (grade 3) obesity, as it allows a consistent and long-lasting weight loss, 31 and a significant improvement of metabolic profile, associated to a significant reduction of arterial blood pressure in the majority of subjects.
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This study was aimed at evaluating the effect of morbid obesity and of hypertension, and the effect of decrease in body weight alone, or accompanied by decrease in arterial blood pressure, on LVH, an index of anatomical deterioration of the left ventricle, and on QTc, an index of sympathetic overatcivity.
Patients and methods

Obese patients
Obese patients were in a protocol of bariatric surgery (laparoscopic adjustable gastric banding, LAGB) for morbid obesity. 32, 33 The protocol of the study was approved by the ); 30 subjects (five men and 25 women) were affected by hypertension, while no subject was affected by diabetes mellitus. As for obese patients, only patients without any evidence of cardiac disease, according to past history, clinical conditions and electrocardiographic assessment, and not using drugs known to affect QTc, were considered. ECG ECG in both groups was carried out after an overnight fast and rest, and on the same occasion arterial blood pressure was evaluated by the same physician, using the same sphygmomanometer with an appropriate cuff. Arterial hypertension was assumed when systolic/diastolic blood pressure was 4140/90 mmHg, or when subjects were under antihypertensive treatment. Clinical and ECG characteristics of the two groups are shown in Table 1 . Left ventricular mass and LVH Left ventricular mass (LVM) was calculated, through ECG reading, as Cornell voltage-duration product ((RaVL þ SV3) Á QRS in mm ms, with an adjustment of 6 mm in women)). These composite ECG criteria detect LVH with about 95% specificity in healthy people and above 70% sensitivity in obese and in hypertensive subjects. [37] [38] [39] In addition, this approach allows direct evaluation of LVM. [40] [41] [42] LVH was assumed for measures of LVM above 1713 mm ms in women and above 2440 mm ms in men. 37 QTc interval QT intervals were measured manually from the onset of the interval between Q and S waves of the electrocardiogram to the end of the T wave on the isoelectric baseline, and corrected according to Bazett's formula (QTc ¼ QT/ORR). 43 When a T wave could not be reliably determined, the lead was excluded from analysis. 44 QT interval was measured in at least 10 leads in each subject.
Statistical analysis
Inter-group comparisons were performed by one-way analysis of variance (ANOVA), followed by Scheffè's multiple comparison test. Intra-group comparisons were performed by two-tailed Student's t-test for paired samples. The frequency of LVH was compared by w 2 . Pairwise correlation was also calculated between changes of clinical conditions and change of LVM in obese subjects undergoing weight loss. Po0.05 was considered statistically significant. Table 1 shows the clinical and ECG data of obese and control subjects, divided into normotensive and hypertensive. In both groups, hypertensive subjects were older than normotensive subjects. Serum electrolytes were always within normal values (not shown). Cornell voltage-duration product and QTc were longer in obese-AH, obese, and lean-AH than in lean controls; the difference of Cornell voltageduration product was due to longer QRS duration and higher RaVL, while SV 3 was higher in lean-AH than in normotensive obese and in controls. These results did not change when obese diabetic patients (n ¼ 12) were excluded from calculations.
Results
During the follow-up period, three obese normotensive subjects became hypertensive, while 15 previously hypertensive subjects became normotensive, so that the number of normotensive subjects increased by 12. Subjects with diabetes mellitus declined during the follow-up period from 6 to 3 in the former group and from 6 to 2 in the latter group; waist circumference, visceral and subcutaneous fat, insulin levels, and HOMA decreased to the same extent in both groups. Table 2 shows changes of clinical and ECG data of obese patients who were normo-or hypertensive 1 y after bariatric surgery, that is, after slimming; in the 87 subjects normotensive after 1 y (either since the beginning or becoming normotensive during the 1-y follow-up) a significant decrease in Cornell voltage-duration product was found, together with a significant decrease in SV 3 voltage; in the 29 subjects hypertensive after 1 y (either since the beginning or becoming hypertensive during the 1-y follow-up), no significant change occurred, so that Cornell voltage-duration product was higher than in lean controls. In contrast, QTc decreased in both groups of subjects. After weight loss, Po0.01 vs obese-AH. HOMA ¼ insulin (mU/ml) Á glucose (mmol/l)/22.5. 35 Obesity, hypertension, LVH, QT interval AE Pontiroli et al no changes were observed in serum electrolytes (Na, K, Ca, Mg, P, not shown). The decrease in Cornell voltage-duration product was proportional to its initial value (r ¼ 0.357, P ¼ 0.0001). BMI decrease after surgery was not different in the two groups of subjects; the only clinical data that correlated with decrease in Cornell voltage-duration product was decrease in diastolic blood pressure (r ¼ 0.186, Po0.05); decreases in BMI, waist circumference, visceral and subcutaneous fat, insulin, and HOMA were not correlated. These results did not change when diabetic patients were excluded from calculations. Figure 1 shows the prevalence of LVH in the four groups of subjects at baseline; among obese subjects re-evaluated after 1 y, prevalence of LVH decreased from 29 to 21 in subjects who were normotensive, and increased from 8 to 13 in subjects who were hypertensive (w 2 ¼ 9.118, P ¼ 0.0025) ( Figure 2 ).
Discussion
In this study, Cornell voltage-duration product and QTc were higher in morbidly obese subjects, with or without hypertension, and in lean hypertensive subjects than in lean controls; as a consequence, LVH was more frequent in morbidly obese subjects, with or without hypertension, and in lean hypertensive subjects than in lean controls. These data agree with previous studies showing that obesity and hypertension are a cause of increased frequency of LVH and are associated with sympathetic overactivity. 5, 6, [13] [14] [15] [16] 39, 42 Sustained and prolonged haemodynamic burden is required to induce structural changes of the left ventricle as it happens in long-lasting obesity and in hypertension; a different explanation might be valid for prolonged QTc, an index of sympathetic overactivity, a situation which is present in both obesity and hypertension, especially when the two conditions co-exist. 16 During the 1-y follow-up, obese patients lost a significant amount of body weight due to bariatric surgery and lowcalorie diet. This weight loss was associated with a significant shortening of QTc in all subjects, in agreement with previous studies in which decrease in body weight was obtained through a low-calorie diet for a prolonged period of time. 23, 28, 30 Cornell voltage-duration product decreased in subjects who, after 1 y, were normotensive, but not in subjects who, after 1 y, were hypertensive. As a consequence, prevalence of LVH decreased in the first group and increased in the second group. The decrease in Cornell voltage-duration product was due to a significant reduction of SV 3 , and due to a nonsignificant shortening of QRS, similar in the two groups. This finding supports and expands previous studies, obtained through echocardiography, 21, 22 in which the prevalence of LVH decreased through reduction of body weight and normalisation of blood pressure. In older studies, which report conflicting results as to LVH, blood pressure was not considered. 17, 20 Therefore, we propose that weight loss has a different effect on QTc and on LVH, depending on the disappearance or persistence of hypertension.
Sympathetic activation contributes to obesity-induced hypertension; recent observations suggest that leptin and its multiple interactions with other neurochemical pathways in the hypothalamus 45 may represent a partial link between excess weight gain and increased sympathetic activity; 42, 43 leptin is reduced after weight loss, 46 and at least two studies have shown a positive effect of body weight reduction on sympathetic nerve traffic. 47, 48 For LVH a different explanation is possible; subjects with increased prevalence of LVH at 1 y were older, were hypertensive, and had a longer duration of obesity, and hypertension 5, 6, 39, 42 and duration of obesity 49 are risk factors Obesity, hypertension, LVH, QT interval AE Pontiroli et al for LVH. Reversibility of hypertension is possible with prolonged treatment with various antihypertensive drugs that lead to sustained reduction of the haemodynamic impact; 50 Fagerberg et al 51 found that reduced sodium intake coupled with reduced energy intake is more effective than reduced energy intake alone in reducing blood pressure in obese-hypertensive patients; finally, we should recall that, with all surgical techniques such as bilio-pancreatic diversion, gastric by pass, and gastric banding, many subjects remain hypertensive, whatever the amount of weight loss; 32,52-54 even more important, in the Swedish obesity study it was shown that surgery does not prevent development of arterial hypertension. 55 At present, there is only one long-term study showing that, in spite of these limitations, all-cause mortality and cardiovascular mortality are lower in obese subjects with weight loss due to bariatric surgery than in subjects remaining obese. 56 
Study limitations
First, the method we used, highly referenced, does not allow direct comparisons with data obtained through echocardiography. However, the trends indicated by our data support and expand previous observations. 21, 22 Second, it might be that with a more prolonged follow-up, and with a more aggressive antihypertensive treatment, we could observe decrease in blood pressure and/or of LVH also in the group of 29 subjects who remained hypertensive after 1 y, but we have chosen the 1-y interval to compare with the majority of studies performed so far. A more detailed answer to the latter question will probably come from a longer follow-up (7 y), which is under way at our institutions.
Conclusions
Effective weight loss can significantly reduce QTc, indicating a better control of sympathetic activity. When concomitant hypertension disappears, weight loss also reduces LVH. As a consequence, in patients remaining hypertensive, aggressive pharmacological treatment is indicated to correct LVH.
